Exoskeletons: new freedom or a privilege?

Use only in tightly limited clinical settings reaches 34 percent with 61 votes.

Offer when proven useful with clear medical criteria reaches 34 percent with 60 votes.

Make them broadly accessible as mobility aids reaches 32 percent with 58 votes.

They must support people and never replace care reaches 32 percent with 57 votes.

Use them alongside care where they add real value reaches 35 percent with 63 votes.

Automate routine support wherever it is reliable reaches 33 percent with 59 votes.

Public health and care systems should cover most costs reaches 33 percent with 59 votes.

Public funding with reasonable co-payments reaches 32 percent with 58 votes.

Users and the market should bear most of the cost reaches 35 percent with 62 votes.